Early Direct Oral Anticoagulant Initiation After Intracranial Hemorrhage Among Japanese Patients With Nonvalvular Atrial Fibrillation ― SAFE-ICH Registry 12-Month Outcomes ―
Background: Understanding the effects of early direct oral anticoagulant (DOAC) (re)initiation after intracranial hemorrhage (ICH) in atrial fibrillation is crucial. Previous 30-day outcomes in the SAFE-ICH Registry showed acceptable ischemic/hemorrhagic risks; therefore, we evaluated the 12-month outcomes.
Authors
- Teruyuki Hirano (ORCID: https://orcid.org/0000-0003-2094-2428)
- Yasuyuki Iguchi (ORCID: https://orcid.org/0000-0002-6662-0611)
- Rei Kondo
- Shouhei Noshiro (ORCID: https://orcid.org/0000-0001-5136-8647)
- Yuka Terasawa (ORCID: https://orcid.org/0000-0002-3704-7369)
- Kanta Tanaka (ORCID: https://orcid.org/0000-0002-3291-5083)
- Ḱazunori Toyoda (ORCID: https://orcid.org/0000-0002-8346-9845)
- Michiko Yokosawa (ORCID: https://orcid.org/0009-0008-5425-5523)
- Takahiro Ogishima (ORCID: https://orcid.org/0000-0003-0424-8129)
- Taketo Hatano (ORCID: https://orcid.org/0000-0002-0047-6901)
- Masatoshi Koga (ORCID: https://orcid.org/0000-0002-6758-4026)
- Shigeru Fujimoto (ORCID: https://orcid.org/0000-0003-4564-7396)
- Fumio Miyashita (ORCID: https://orcid.org/0000-0002-3503-6711)
- Shigeo Yamashiro (ORCID: https://orcid.org/0000-0003-4634-803X)
- Yasushi Takagi (ORCID: https://orcid.org/0000-0002-9643-1272)
- Atsushi Takita
- Ryo Itabashi (ORCID: https://orcid.org/0000-0001-8098-457X)
- Tatemi Todaka
- Nobukazu Komoribayashi (ORCID: https://orcid.org/0009-0002-9343-4862)
- Yukako Yazawa (ORCID: https://orcid.org/0000-0003-3891-0221)
- Toshihiro Ueda (ORCID: https://orcid.org/0000-0002-1148-1853)
- Michikazu Nakai (ORCID: https://orcid.org/0000-0003-2240-1510)
- Kazutaka Sonoda (ORCID: https://orcid.org/0000-0002-1406-1336)
- Joji Hagii
- Nobuyuki Ohara (ORCID: https://orcid.org/0000-0003-4033-9183)
- Keiko Maezono-Kandori (ORCID: https://orcid.org/0000-0002-3761-0529)
- Kunikazu Yoshimura (ORCID: https://orcid.org/0000-0002-4510-2858)
- Hiroharu Kataoka (ORCID: https://orcid.org/0000-0001-8507-7557)
- Shuji Arakawa (ORCID: https://orcid.org/0000-0003-1969-2564)
- Tsuyoshi Izumo (ORCID: https://orcid.org/0000-0001-8778-2698)
- Shuhei Okazaki (ORCID: https://orcid.org/0000-0002-5789-2893)
- Kazumi Kimura
- Kaori Miwa (ORCID: https://orcid.org/0000-0002-7948-3636)
- Masanori Kinosada (ORCID: https://orcid.org/0000-0002-9935-5885)
- Kuniyasu Wada
- Hiroyuki Ohnishi
- Masako Sugimoto
- Masafumi Ihara
- Hiroaki Kobayashi
- on behalf of the SAFE-ICH Registry Group
- Toshiichi Watanabe
- Yasuhiro Ito
Institutions
- Jikei University School of Medicine (JP)
- University of Miyazaki (JP)
- Kansai Medical University (JP)
- Jichi Medical University (JP)
- St. Marianna University School of Medicine (JP)
- Daiichi Sankyo (Germany) (DE)
- Iwate Medical University (JP)
- Kyorin University (JP)
- Kumamoto City Hospital (JP)
- Kurashiki Central Hospital (JP)
- Osaka National Hospital (JP)
- Iwate Prefectural Central Hospital (JP)
- Toyota Memorial Hospital (JP)
- Saiseikai Kumamoto Hospital (JP)
- Ohkawara Neurosurgical Hospital (JP)
- Daiichi Sankyo (United Kingdom) (GB)
- Yamagata City Hospital Saiseikan (JP)
- Daiichi-Sankyo (Japan) (JP)
- Japanese Red Cross Kumamoto Hospital (JP)
- National Cerebral and Cardiovascular Center (JP)
- Ohnishi Neurological Center (JP)
- Obihiro Kosei General Hospital (JP)
- Nakamura Memorial Hospital (JP)
- Kagoshima City Hospital (JP)
- Fuji Heavy Industries Health Insurance Society Ota Memorial Hospital (JP)
- Kohnan Hospital (JP)
- Saiseikai Fukuoka General Hospital (JP)
- Musashino Red Cross Hospital (JP)
- Nippon Steel Yawata Memorial Hospital (JP)
- Kokura Memorial Hospital (JP)
- Kobe City Medical Center General Hospital (JP)
- Daiichi Sankyo (United States) (US)
- Gifu University (JP)
- Hirosaki Stroke and Rehabilitation Center (JP)
- Nippon Medical School (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-10-05
- DOI
- https://doi.org/10.1253/circrep.cr-26-0249
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Boston Scientific Corporation
- National Cerebral and Cardiovascular Center
- Otsuka Pharmaceutical
- Pfizer Japan
- Bayer Yakuhin
- Daiichi Sankyo Europe